The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
Abstract
OBJECTIVE: Recent studies suggest the beneficial effects of metformin on glucose metabolism may be microbially mediated. We examined the association of type 2 diabetes, metformin, and gut microbiota in community-dwelling Colombian adults. On the basis of previous research, we hypothesized that metformin is associated with higher levels of short-chain fatty acid (SCFA)–producing and mucin-degrading microbiota. RESEARCH DESIGN AND METHODS: Participants were selected from a larger cohort of 459 participants. The present analyses focus on the 28 participants diagnosed with diabetes—14 taking metformin— and the 84 participants without diabetes who were matched (3-to-1) to participants with diabetes by sex, age, and BMI. We measured demographic information, anthropometry, and blood biochemical parameters and collected fecal samples from which we performed 16S rRNA gene sequencing to analyze the composition and structure of the gut microbiota. RESULTS: We found an association between diabetes and gut microbiota that was modified by metformin use. Compared with participants without diabetes, participants with diabetes taking metformin had higher relative abundance of Akkermansia muciniphila, a microbiota known for mucin degradation, and several gut microbiota known for production of SCFAs, including Butyrivibrio, Bifidobacterium bifidum, Megasphaera, and an operational taxonomic unit of Prevotella. In contrast, compared with participants without diabetes, participants with diabetes not taking metformin had higher relative abundance of Clostridiaceae 02d06 and a distinct operational taxonomic unit of Prevotella and a lower abundance of Enterococcus casseliflavus. CONCLUSIONS: Our results support the hypothesis that metformin shifts gut microbiota composition through the enrichment of mucin-degrading A. muciniphila as well as several SCFA-producing microbiota. Future studies are needed to determine if these shifts mediate metformin’s glycemic and anti-inflammatory properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Biguanides/metformin, the first-line therapeutics for T2D, modifies microbiota leading to an increase in A. muciniphila, as well as several SCFA-producing microbiota, favoring an improvement on mucin-producing goblet cells, pro-inflammatory IL-6, and glucose tolerance [304].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [304]
In the citing paper
“In human diabetic individuals, metformin was shown to shift gut microbiota composition to predominantly short-chain fatty-acid producing microbes”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as de la Cuesta-Zuluaga et al. 2017
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · cited 2×
“pairwise tests among groups of participants using the unpaired Wilcoxon rank sum test, and finally uses LDA to estimate the effect size of each differentially abundant OTU (24).”
MethodKozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,112
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundLinking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513 · cited 1×
“Prevotella has been associated with carbohydrate-baseddiets anddegradation of complex polysaccharides (26), whereas E.”
BackgroundCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 3×
“abundance of Akkermansia muciniphila (11–13), a mucin-degrading bacteria that has been shown to reverse metabolic disorders (1,12).”
BackgroundInfluentialGut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundGut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851 · cited 1×
“through effects on bile acid secretion (31).”
Cited by
Items 101–200 of 731
Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases
Niu, H., Zhou, M., Zogona, D., Xing, Z., Wu, T., Chen, R., Cui, D., Liang, F., & Xu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370658 · Cited by 120
Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood
Bavineni, M., Wassenaar, T. M., Agnihotri, K., Ussery, D. W., Lüscher, T. F., & Mehta, J. L. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz025 · Cited by 117
Brandt, A., Hernández-Arriaga, A. M., Kehm, R., Sánchez, V., Jin, C. J., Nier, A., Baumann, A., Camarinha‐Silva, A., & Bergheim, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-43228-0 · Cited by 115
Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome
de Jonge, P. A., Wortelboer, K., Scheithauer, T. P. M., van den Born, B. H., Zwinderman, A. H., Nóbrega, F. L., Dutilh, B. E., Nieuwdorp, M., & Herrema, H. (2022) · Nature Communications · doi:10.1038/s41467-022-31390-5 · Cited by 118
Effects of metformin on the gut microbiota: A systematic review
Petakh, P., Kamyshna, I. I., & Kamyshnyi, O. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101805 · Cited by 129
“In the Firmicutes phylum, Bacillus decreased in one study [27], while Blautia [13,25] and Butyrivibrio [23,25] increased in two studies each.”
BackgroundResultInfluentialZhu, X., Shen, J., Feng, S., Huang, C., Wang, H., Huo, F., & Liu, H. (2023) · Microbiome · doi:10.1186/s40168-023-01567-1 · Cited by 113
“Many studies have reported that metformin affects the host metabolism through the gut microbiota [8, 10, 13].”
BackgroundThe central role of the gut microbiota in the pathophysiology and management of type 2 diabetes
Baars, D. P., Fondevila, M. F., Meijnikman, A. S., & Nieuwdorp, M. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.017 · Cited by 119
Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
Rizk, M. G., & Thackray, V. G. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa177 · Cited by 104
Dao, M. C., Belda, E., Prifti, E., Everard, A., Kayser, B. D., Bouillot, J., Chevallier, J., Pons, N., Chatelier, E. L., Ehrlich, S. D., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00140.2019 · Cited by 114
Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon
Cai, R., Chen, C., Chen, J., Xu, X., Ding, C., & Gu, B. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1735606 · Cited by 110
“Although there is little evidence on the direct effects of nonantibiotics on the colon mucus layer and mucins, several studies reported that naproxen could reduce the expression of gastric mucins and that metformin could increase the abundance of the mucus-degrading Akkermansia muciniphila and SCFA-producing microbiot…”
BackgroundAkkermansia muciniphila plays critical roles in host health
Zhao, Q., Yu, J., Hao, Y., Zhou, H., Hu, Y., Zhang, C., Zheng, H., Wang, X., Zeng, F., Hu, J., et al. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2037506 · Cited by 111
“…regard, gavage of A. muciniphila to mice fed a high-fat diet without metformin treatment significantly improved glucose tolerance and alleviated adipose tissue inflammation by promoting the infiltration of Foxp3þ Tregs in visceral adipose tissue (Shin et al. 2014; de la Cuesta-Zuluaga et al. 2017).”
BackgroundThe emerging role of the small intestinal microbiota in human health and disease
Ruigrok, R. A. A. A., Weersma, R. K., & Vila, A. V. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2201155 · Cited by 110
Frugé, A. D., Pol, W. V. D., Rogers, L. Q., Morrow, C. D., Tsuruta, Y., & Demark‐Wahnefried, W. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.08.164 · Cited by 111
Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes
Zhu, T., & Goodarzi, M. O. (2020) · Current Nutrition Reports · doi:10.1007/s13668-020-00307-3 · Cited by 118
Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
Verdura, S., Cuyàs, E., Martín-Castillo, B., & Menéndez, J. A. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1633235 · Cited by 106
Microbiota and Diabetes Mellitus: Role of Lipid Mediators
Salazar, J. J., Angarita, L., Morillo, V., Navarro, C., Martínez, M. S., Chacín, M., Torres, W., Rajotia, A., Rojas, M., Cano, C., et al. (2020) · Nutrients · doi:10.3390/nu12103039 · Cited by 106
Xu, R., Zhang, Y., Chen, S., Zeng, Y., Fu, X., Chen, T., Luo, S., & Zhang, X. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2044286 · Cited by 103
Wang, Y., Zhao, J., Qin, Y., Yu, Z., Zhang, Y., Ning, X., & Sun, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908219 · Cited by 110
“Animal and human studies have shown that metformin can increase the abundance of Akkermansia in the gut microbiota (73, 74).”
BackgroundSu, H., Xie, L., Xu, Y., Ke, H., Bao, T., Li, Y., & Chen, W. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03338 · Cited by 99
The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
Huang, Y., Xin, W., Xiong, J., Yao, M., Zhang, B., & Zhao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837500 · Cited by 109
The alteration of gut microbiota in newly diagnosed type 2 diabetic patients
Chen, P., Chien, Y., & Yang, S. (2018) · Nutrition · doi:10.1016/j.nut.2018.11.019 · Cited by 98
Zhang, M., Feng, R., Yang, M., Cheng, Q., Wang, Z., Liu, W., & Ma, J. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000717 · Cited by 93
Que, Y., Cao, M., He, J., Zhang, Q., Chen, Q., Yan, C., Lin, A., Yang, L., Wu, Z., Zhu, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722206 · Cited by 98
“This study systematically evaluated the differences in intestinal flora between T2DM patients and healthy controls based on 1143 samples from China (16, 31), Colombia (32), Pakistan (28), Africa (30), Mexico (29).”
BackgroundXu, S., Dou, Y., Ye, B., Wu, Q., Wang, Y., Hu, M., Rong, X., & Guo, J. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.032 · Cited by 81
Is metformin poised for a second career as an antimicrobial?
Malik, F. R., Mehdi, S. F., Ali, H., Patel, P., Basharat, A., Kumar, A., Ashok, F., Stein, J., Brima, W., Malhotra, P., et al. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2975 · Cited by 95
“In addition to the antimicrobial effects noted earlier, several studies show that metformin influences the composition of the microbial population of the gut.(4,82,83) Research links the gut microbiota to a wide range of diseases including colon cancer,(84,85) rheumatoid arthritis,(86) cardiovascular diseases,(87,88)…”
BackgroundMechanisms of action of metformin with special reference to cardiovascular protection
Zilov, A. V., Abdelaziz, S. I., Alshammary, A., Zahrani, A. A., Amir, A., Khalil, S. H. A., Brand, K. M. G., Elkafrawy, N., Hassoun, A. A. K., Jahed, S. A., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3173 · Cited by 94
Alteration of gut microbial profile in patients with diabetic nephropathy
Du, X., Liu, J., Yu, X. M., Kong, X., Lv, C., Li, Z., Huang, Y., & Wang, B. (2021) · Endocrine · doi:10.1007/s12020-021-02721-1 · Cited by 96
“1f: In the PG, seven genera were significantly abundant like Acidaminococcus (p= 0.001), Lactobacillus (p= 0.001), Megasphaera (p= 0.001), Mitsuokella (p= 0.000), Olsenella (p= 0.000), Prevotella_7 (p= 0.000), and Sutterella (p= 0.000), moreover, Lachnoclostridium (p= 0.002), Roseburia (p= 0.001), and Tyzzerella_3 (p=…”
BackgroundInfluentialWu, C., Zhao, Y. L., Zhang, Y., Yang, Y., Su, W., Yang, Y., Sun, L., Zhang, F., Yu, J., Wang, Y., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.07.011 · Cited by 94
Gut microbiome differences between metformin‐ and liraglutide‐treated T2 DM subjects
Wang, Z., Saha, S., Horn, S. V., Thomas, E., Traini, C., Sathe, G. M., Rajpal, D. K., & Brown, J. R. (2017) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.9 · Cited by 94
The gut microbiome of laboratory mice: considerations and best practices for translational research
Ericsson, A. C., & Franklin, C. L. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09863-7 · Cited by 98
“As the type strain for the order Verrucomicrobiales, Akkermansia muciniphila has gained attention for several reports of its association with increased insulin sensitivity, positive glucose regulation, and possibly an adjunct mechanism through which the antihyperglycemic agent metformin may act (Shin et al. 2014; Cues…”
BackgroundRosário, D., Benfeitas, R., Bidkhori, G., Zhang, C., Uhlén, M., Shoaie, S., & Mardinoğlu, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00775 · Cited by 92
The role of the microbiota in the management of intensive care patients
Szychowiak, P., Villageois-Tran, K., Patrier, J., Timsit, J., & Ruppé, É. (2022) · Annals of Intensive Care · doi:10.1186/s13613-021-00976-5 · Cited by 94
Singh, H., Miyamoto, S., Darshi, M., Torralba, M., Kwon, K., Sharma, K., & Pieper, R. (2020) · Microorganisms · doi:10.3390/microorganisms8091347 · Cited by 85
“muciniphila as compared to non-diabetic controls in the gut microbiota, perhaps due to the intake of metformin [24].”
BackgroundSu, M., Hu, R., Tang, T. F., Tang, W., & Chunxia, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1085092 · Cited by 82
“Dysbacteriosis in T2DM patients leads to an increase in Gram-negative bacteria–producing lipopolysaccharides (LPSs) and a decrease in the microbiota that protect the intestinal mucosal barrier (26).”
BackgroundHasan, S., Aho, V. T. E., Pereira, P. A. B., Paulin, L. G., Koivusalo, S. B., Auvinen, P., & Eriksson, J. G. (2017) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13252 · Cited by 87
Walker, R. L., Vlamakis, H. C., Lee, J. W. J., Besse, L. A., Xanthakis, V., Vasan, R. S., Shaw, S. Y., & Xavier, R. J. (2021) · Genome Medicine · doi:10.1186/s13073-021-01007-5 · Cited by 90
Gutiérrez‐Repiso, C., Hernández‐García, C., García‐Almeida, J. M., Bellido, D., Martín‐Núñez, G. M., Sánchez‐Alcoholado, L., Alcaide‐Torres, J., Sajoux, I., Tinahones, F. J., & Moreno‐Indias, I. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900167 · Cited by 80
Microbiota and Obesity: Where Are We Now?
Ballini, A., Scacco, S., Boccellino, M., Santacroce, L., & Arrigoni, R. (2020) · Biology · doi:10.3390/biology9120415 · Cited by 88
“Metformin, a well-known drug used for diabetic treatment, is able to act directly on microbiota [29,30].”
BackgroundApproach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 90
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R. D., Pontefract, B., Mishcon, H. R., Black, C. A., Sutton, S. C., & Theberge, C. R. (2022) · Kompass Nutrition & Dietetics · doi:10.1159/000523712 · Cited by 87
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Portincasa, P., Khalil, M., Graziani, A., Frühbeck, G., Baffy, G., Garruti, G., Ciaula, A. D., & Bonfrate, L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.002 · Cited by 84
Flaxseed gum reduces body weight by regulating gut microbiota
Luo, J., Li, Y., Mai, Y., Gao, L., Ou, S., Wang, Y., Liu, L., & Peng, X. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.05.042 · Cited by 77
Fianchi, F., Liguori, A., Gasbarrini, A., Grieco, A., & Miele, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126485 · Cited by 82
“For example, Metformin has been revealed to act as a potent anti-inflammatory drug through a modulation of the gut microbiota [159–161]: In particular, it is able to produce a favorable change in the gut microbiota composition, with an increase in the relative abundance of Bifidobacterium and Akkermansia [162].”
BackgroundZhang, L., Liu, J., Jin, T. Y., Qin, N., Ren, X., & Xia, X. (2022) · Food & Function · doi:10.1039/d2fo02702j · Cited by 81
Bataineh, M. T. A., Dash, N. R., Lassen, P. B., Banimfreg, B. H., Nada, A. M., Belda, E., & Clément, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-66598-2 · Cited by 84
Zhao, J., Li, Y., Sun, M., Yu, C., Li, J.-Y., Wang, S.-H., Yang, D., Guo, C., Du, X., Zhang, W., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i8.708 · Cited by 81
Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Tsai, H.-J., Tsai, W., Hung, W., Hung, W., Chang, C.-C., Dai, C., & Tsai, Y. (2021) · Nutrients · doi:10.3390/nu13082679 · Cited by 81
“For example, previous studies suggested that metformin may be related to a higher abundance of A muciniphila and several butyrate-producing bacteria to maintain the glycemic status in T2D patients [55,56].”
Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes
Sharma, B. R., Jaiswal, S., & Veeranna, R. P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113148 · Cited by 79
Xie, C., Qi, C., Zhang, J., Wang, W., Meng, X., Aikepaer, A., Lin, Y., Su, C., Liu, Y., Feng, X., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116791 · Cited by 76
Understanding the action mechanisms of metformin in the gastrointestinal tract
Cheng, M., Ren, L., Jia, X., Wang, J., & Cong, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1347047 · Cited by 84
“…of bacteria that generate short-chain fatty acids (SCFAs) in the gut of people with T2DM, leadingtoanincreaseinSCFAslevelsinthecolon, ultimatelyimproving host metabolism (Forslund et al., 2015; Zhang et al., 2015; Wu et al., 2017a; de la Cuesta-Zuluaga et al., 2017; Mueller et al., 2021).”
BackgroundZhang, L. R., Wang, Y., Wu, F., Wang, X., Feng, Y., & Wang, Y. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.036 · Cited by 76
Deng, L., Yang, Y., & Xu, G. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159234 · Cited by 88
Dongiovanni, P., Paolini, E., Corsini, A., Sirtori, C. R., & Ruscica, M. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13519 · Cited by 77
Kumar, R., Sharma, A., Gupta, M., Padwad, Y. S., & Sharma, R. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-09576-z · Cited by 75
“Emerging evidences have suggested a link between gut dysbiosis and the development of inflammation, insulin resistance, and type 2 diabetes [52], and that some effects of the drug metformin may also be mediated by changes in the gut microbiota [53].”
BackgroundYang, Y., Wang, Q., Xu, W., Yu, J., Zhang, H., & Wu, C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113749 · Cited by 73
Hu, B., Ye, C., Leung, E. L., Zhu, L., Hu, H., Zhang, Z., Zheng, J., & Liu, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104942 · Cited by 73
Hatton, G. B., Madla, C. M., Rabbie, S. C., & Basit, A. W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.06.054 · Cited by 71
Gowd, V., Xie, L., Zheng, X., & Chen, W. (2019) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2019.1576025 · Cited by 73
“The ratio of Bacteroidetes to Firmicutes as well as the ratio of the Bacteroides–Prevotella group to Clostridium coccoides– Eubacterium rectale group and enrichment in the Betaproteobacteria class was positively correlated with plasma glucose concentrations, suggesting that bacterial species are more specific for DM a…”
BackgroundInfluentialPonziani, F. R., Nicoletti, A., Gasbarrini, A., & Pompili, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919848184 · Cited by 73
Anti-fatigue property of the oyster polypeptide fraction and its effect on gut microbiota in mice
Xiao, M., Lin, L., Chen, H., Ge, X., Huang, Y., Zheng, Z., Li, S., Pan, Y., Liu, B., & Zeng, F. (2020) · Food & Function · doi:10.1039/d0fo01713b · Cited by 69
Wu, Q., Wu, S., Yang, C., Zhang, Z., Mao, G., Li, S., Yang, Y., Zhang, X., Wu, M., & Tong, H. (2021) · Food & Function · doi:10.1039/d0fo03329d · Cited by 72
The Gut Microbiome, Metformin, and Aging
Induri, S. N. R., Kansara, P., Thomas, S. C., Xu, F., Saxena, D. B., & Li, X. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051920-093829 · Cited by 70
Liu, W., Luo, Z., Zhou, J., & Sun, B. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.853771 · Cited by 77
Segers, A., & de Vos, W. M. (2023) · Microbiome Research Reports · doi:10.20517/mrr.2023.05 · Cited by 71
Metformin, Cognitive Function, and Changes in the Gut Microbiome
Rosell-Díaz, M., & Fernández‐Real, J. M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad029 · Cited by 72
Zikou, E., Dovrolis, N., Dimosthenopoulos, C., Gazouli, M., & Makrilakis, K. (2023) · Nutrients · doi:10.3390/nu15214663 · Cited by 71
“This was crucial because certain anti-diabetic medications, such as metformin [74] and GLP-1 RAs [75], have been shown to interact with and partially exert their actions through the intestinal microbiome.”
BackgroundHuang, J., Chen, P., Xiang, Y., Liang, Q., Wu, T., Liu, J., Zeng, Y., Zeng, H., Liang, X., & Zhou, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108717 · Cited by 76
de la Cuesta‐Zuluaga, J., Corrales-Agudelo, V., Carmona, J. A., Abad, J. M., & Escobar, J. S. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.281 · Cited by 68
Self-citationGut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
Chen, L., Zhi, X., Zhang, K.-K., Wang, L., Li, J.-H., Liu, J.-L., Xu, L., Yoshida, J. S., Xie, X., & Wang, Q. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111946 · Cited by 72
Ma, W., Chen, J., Meng, Y., Yang, J., Cui, Q., & Zhou, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01336 · Cited by 66
“…et al., 2013), cardiovascular diseases (Wang et al., 2011; Tang et al., 2013) and diabetes (Larsen et al., 2010; Qin et al., 2012; Karlsson et al., 2013; Forslund et al., 2015; de la Cuesta-Zuluaga et al., 2017; Wu et al., 2017), obesity (Lee and Ko, 2014; Shin et al., 2014; Zhang et al., 2015).”
BackgroundMetformin-induced reductions in tumor growth involves modulation of the gut microbiome
Broadfield, L. A., Saigal, A., Szamosi, J. C., Hammill, J. A., Bezverbnaya, K., Wang, D., Gautam, J., Tsakiridis, E. E., Pastena, F. D., McNicol, J. D., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101498 · Cited by 69
Pan, M., Qian, C., Huo, S., Wu, Y., Zhao, X., Ying, Y., Wang, B., Yang, H., Yeerken, A., Wang, T., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2024.2447834 · Cited by 74
“41 Therefore, we performed targeted SCFA metabolite analysis on the supernatant of A. muciniphila cultures supplemented with lactate.”
Dietary copper-fructose interactions alter gut microbial activity in male rats
Song, M., Li, X., Zhang, X., Shi, H., Vos, M. B., Wei, X., Wang, Y., Gao, H., Rouchka, E. C., Yin, X., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00378.2016 · Cited by 73
“Moreover, the disrupted gut barrier function was associated with gut microbiota dysbiosis, characterized by Akkermansia depletion, which has been well documented to be critical for maintaining gut barrier function (13, 14, 18).”
BackgroundEjtahed, H.-S., Tito, R. Y., Siadat, S.-D., Hasani-Ranjbar, S., Hoseini-Tavassol, Z., Rymenans, L., Verbeke, K., Soroush, A.-R., Raes, J., & Larijani, B. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0826 · Cited by 63
Metformin: Past, Present, and Future
Chaudhary, S., & Kulkarni, A. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01539-1 · Cited by 68
Silamiķele, L., Silamiķelis, I., Ustinova, M., Kalniņa, Z., Elbere, I., Petrovska, R., Kalniņa, I., & Kloviņš, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626359 · Cited by 68
“Another direction of metformin’s effects on the gut microbiome is the increased abundance of the mucin-degrading Akkermansia muciniphila (12).”
BackgroundKamyshnyi, O., Matskevych, V. M., Lenchuk, T., Strilbytska, O. M., Storey, K. B., & Lushchak, O. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112230 · Cited by 65
“, may enhance the antidiabetic effect of metformin [131].”
Zhou, Y., Zhang, F., Mao, L., Feng, T., Wang, R. C., Xu, M., Lv, B., & Wang, X. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02958-0 · Cited by 64
“Through 1H NMR spectroscopy, we found that the abundance of acetate, propionate, butyrate and valerate were decreased in the IBS group, which supported the view of suggesting that patients with IBS had lower levels of SCFAs [89].”
BackgroundInfluentialLakshmanan, A. P., Murugesan, S., Khodor, S. A., & Terranegra, A. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03631-0 · Cited by 66
Kesika, P., Sivamaruthi, B. S., & Chaiyasut, C. (2019) · BioMed Research International · doi:10.1155/2019/1531567 · Cited by 67
Elbere, I., Silamiķelis, I., Dindune, I. I., Kalniņa, I., Briviba, M., Zaharenko, L., Silamiķele, L., Rovīte, V., Gudrā, D., Konrāde, I., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241338 · Cited by 68
Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
Ibrahim, S. M., Lowe, J. R., Bramante, C. T., Shah, S., Klatt, N. R., Sherwood, N. E., Aronne, L. J., Puskarich, M. A., Tamariz, L. J., Palacio, A., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.587801 · Cited by 61
Peng, D., Tian, W., An, M., Chen, Y., Zeng, W., Zhu, S., Li, P., & Du, B. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.133974 · Cited by 62
Cao, Y., Yao, G., Sheng, Y., Li, Y., Wang, Z., Yang, Z. Y., Zhuang, P., & Zhang, Y. (2019) · Journal of Diabetes Research · doi:10.1155/2019/1872134 · Cited by 62
“to produce short-chain fatty acids (SCFAs) [27], which provide energy and nutrition to the intestinal epithelium, mitigate inflammation, and regulate glucose metabolism [28].”
BackgroundMetformin effect on gut microbiota: insights for HIV-related inflammation
Ouyang, J., Isnard, S., Lin, J. C.-Y., Fombuena, B., Marette, A., Routy, B., Chen, Y., & Routy, J. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00267-2 · Cited by 61
Wan, Y., Jiang, J., Lu, M., Tong, W., Zhou, R., Li, J., Yuan, J., Wang, F., & Li, D. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1760711 · Cited by 64
“In the analysis of individual gut microbial taxon through lactation time, data were arcsine square root transformed and analyzed by the linear mixed model.(51) When examining the influence of maternal prenatal factors (including geographic location, gestational hypertensive status, and maternal age) on the changing tr…”
MethodFrom nitrate to NO: potential effects of nitrate-reducing bacteria on systemic health and disease
Liu, H., Huang, Y., Huang, M., Wang, M., Ming, Y., Chen, W., Chen, Y., Tang, Z., & Jia, B. (2023) · European Journal of Medical Research · doi:10.1186/s40001-023-01413-y · Cited by 58
Díaz-Perdigones, C. M., Muñoz‐Garach, A., Alvarez-Bermudez, M. D., Moreno‐Indias, I., & Tinahones, F. J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112448 · Cited by 61
Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era
Martínez-López, Y. E., Esquivel-Hernandez, D. A., Sánchez-Castañeda, J. P., Neri-Rosario, D., Guardado‐Mendoza, R., & Reséndis-Antonio, O. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2111952 · Cited by 65
Kamath, S., Stringer, A. M., Prestidge, C. A., & Joyce, P. M. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2233900 · Cited by 60
The Role of the Microbiome in Drug Response
Pryor, R. E., Martínez‐Martínez, D., Quintaneiro, L. M., & Cabreiro, F. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023612 · Cited by 59
Ying, Y., Liu, S., Wang, Y., Wang, Z., Ding, W., Sun, X., He, K., Feng, Q., & Zhang, X. (2020) · Aging · doi:10.18632/aging.103399 · Cited by 66
“beneficial effects of metformin may be mediated by intestinal microbes [13, 14], metformin treatment increased the abundance of mucin-degrading bacteria and short-chain-fatty-acid–producing microbes [15, 16] and promoted the gut microbiota to produce bsh, a gene encoding a bile salt hydrolase, which was significantly…”
BackgroundPharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes
Caesar, R. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.01.007 · Cited by 58
Zazueta, A., Valenzuela-Pérez, L., Ortiz‐López, N., Pinto-León, A., Torres, V., Guiñez, D., Aliaga, N., Merino, P., Sandoval, A., Covarrubías, N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084387 · Cited by 58
Li, X., Huang, Y., Song, L., Xiao, Y., Lu, S., Xu, J., Li, J., & Ren, Z. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104103 · Cited by 59
Akkermansia muciniphila is Negatively Correlated with Hemoglobin A1c in Refractory Diabetes
Shih, C., Yeh, Y., Lin, C., Yang, L., & Chiang, C.-P. (2020) · Microorganisms · doi:10.3390/microorganisms8091360 · Cited by 62
“muciniphila as a means to promote glucose homeostasis [39,40].”
BackgroundThe Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes
Zhao, X. Y., Zhang, Y., Guo, R., Yu, W., Zhang, F., Wu, F., & Shang, J. (2020) · Journal of Diabetes Research · doi:10.1155/2020/8842651 · Cited by 63
“Studies had shown that the application of metformin could increase the abundance of Akkermansia in a mouse model [28].”
BackgroundBeneficial Bacteria Isolated from Food in Relation to the Next Generation of Probiotics
Sionek, B., Szydłowska, A., Zielińska, D., Neffe‐Skocińska, K., & Kołożyn‐Krajewska, D. (2023) · Microorganisms · doi:10.3390/microorganisms11071714 · Cited by 62
Health Effects and Therapeutic Potential of the Gut Microbe Akkermansia muciniphila
Aja, E., Zeng, A.-P., Gray, W. R., Connelley, K. K., Chaganti, A., & Jacobs, J. P. (2025) · Nutrients · doi:10.3390/nu17030562 · Cited by 60
“Metformin, a pharmaceutical agent used in the management of type 2 diabetes, has also been linked to an increase in A. muciniphila abundance [19,67].”
Metadata
- Authors
- de la Cuesta-Zuluaga, J., Mueller, N. T., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S.
- Affiliations
- Vidarium—Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia
- Johns Hopkins University (US)
- Vidarium - Centro de Investigación en Nutrición Salud y Bienestar (CO)
- Dinámica I.P.S.—Especialista en Ayudas Diagnósticas, Medellin, Colombia
- EPS y Medicina Prepagada Suramericana S.A., Medellin, Colombia
- Corresponding author
- Escobar, Juan S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-14
- Volume
- 40
- Issue
- 1
- Pages
- 54-62
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2553515186
- Cited by
- 704
- References
- 40
- Citations by year
- 2026: 55 · 2025: 69 · 2024: 86 · 2023: 80 · 2022: 106 · 2021: 78 · 2020: 87 · 2019: 62 · 2018: 45 · 2017: 33 · 2016: 1
- FWCI
- 24.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- metformin, Akkermansia muciniphila, gut microbiota, short-chain fatty acids, type 2 diabetes, mucin degradation, Butyrivibrio, Bifidobacterium bifidum, Megasphaera, Prevotella, Clostridiaceae, Enterococcus casseliflavus, fecal microbiota composition, glycemic control
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Adult, Colombia, Diabetes Mellitus, Type 2, Fatty Acids, Volatile, Feces, Female, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Mucins, RNA, Ribosomal, 16S, Case-Control Studies, Verrucomicrobia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.